Welcome to Cohesion Biosciences
Home > Product > Primary Antibody
Bevacizumab CBA1029
Product NameBevacizumab
Cat No: CBA1029
Source: Humanized
Reactivity: Human
Applications: Functional Assay
*Application Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
*Species Reactivity Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
2 mg
5 mg
20 mg
Add to cart Ship in 1 week My orders
Description: Anti-VEGF [Bevacizumab]
Purification: Affinity Chromatography
Clonality: Monoclonal
Form: IgG1, liquid in 10 mmol/L PBS, pH 7.2
Gene Symbol: VEGFA
Alternative Names: VEGF; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF
Entrez Gene (Human): 7422
SwissProt (Human): P15692
Components : Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa.
Storage/Stability : Stored at 2-8°C for at least 4 weeks. Store at -20 °C for 12 months. For long term storage aseptically aliquot and store at -80°C. Avoid repeated freeze/thaw cycles.
Copyright © 2022 Cohesion Biosciences. All Rights Reserved